 | • レポートコード：STR-DC042 • 出版社/出版日：Straits Research / 2019年11月28日 • レポート形態：英文、PDF、154ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：製薬 |
| Single User（1名様用、印刷不可） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User（5名様用） | ￥836,200 (USD5,650) | ▷ お問い合わせ |
| Enterprise Price（法人閲覧用） | ￥1,073,000 (USD7,250) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートでは、動物用皮膚科薬の世界市場について調査・分析し、調査手法、市場概要、薬物別（非ステロイド系抗炎症薬（NSAIDS）、抗生物質、動物用抗真菌薬）分析、動物別（大型動物、小型動物）分析、エンドユーザー別（獣医病院、獣医クリニック）分析、地域別分析、企業概要などを含め次の構成でお届け致します。 ・イントロダクション ・調査手法 ・市場概要 ・動物用皮膚科薬の世界市場：薬物別（非ステロイド系抗炎症薬（NSAIDS）、抗生物質、動物用抗真菌薬） ・動物用皮膚科薬の世界市場：動物別（大型動物、小型動物） ・動物用皮膚科薬の世界市場：エンドユーザー別（獣医病院、獣医クリニック） ・動物用皮膚科薬の世界市場：地域別 ・企業概要 |
Atopic dermatitis is chronic skin disease associated with allergies which is caused by harmless substances like grass, mold spores, house dust mites, and other environmental allergens. Surge in prevalence of chronic skin disorders such as chewing, biting, rubbing is driving the growth of market. Furthermore, high presence of cattle and buffalo suffering from of lumpy skin disease (LSD) in European countries is major reason for boosting the growth of market. For instance, since 2012, LSD has been spread from Africa and the Middle East into south-eastern Europe, affecting European Union (EU) Member countries. Numerous autoimmune and immune-mediated cutaneous diseases such as atopic in cat and dog across the globe is in companion animals is fuelling the growth of market. Surge in number of incidence of anhrax in cattle, deer, cattle, goats, and sheep is supporting the growth of market.
Segmentation insight
The veterinary dermatology drugs market is segmented into drug, animal type and end users.
On the basis of drug the veterinary dermatology drugs market is segmented into non-steroidal anti-inflammatory drugs (NSAIDS), antibiotics, and veterinary antifungal drug. Antibiotics veterinary medicine segment is expected to hold major market share owing to most of skin diseases caused by various bacteria.
Based on the animal type the market is segmented into large animals and small animals. High prevalence of dermatological disorders in small animals such as dog and cat as compared other animal, thus, small animals segment is dominated market and expected to grow in forecast period.
On the basis of end users the market is segmented into veterinary hospitals, veterinary clinics. Veterinary clinics is expected to hold major market share owing to control infectious animal diseases and thus reduce morbidity and mortality rate of animals. Veterinary clinics is cost effective then veterinary hospital thus, large number of patient visit the clinic.
Geographically, veterinary dermatology drugs market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa (LAMEA).
North America is dominating the market & is expected to continue its dominance over the forecast period. This is attributed to increasing adoption of companion animal in developed countries such as U.S., Canada and increasing spending on pet care in this region is boosting the growth of market. For instance, as per American Pet Products Association (APPA) data states that 68.0% of US households, or approximately 86.4 million homes, have at least one pet. However, high prevalence of pruritus, sores, alopecia, masses, eruptions, scales, seborrhea, pustules, and draining tracts in companion animals is fuelling the market growth. Furthermore, increasing technology in veterinary medicine that has lengthen lifespan of veterinary animals is another region which positively influence the market.
Europe is expected to witness second leading region for veterinary dermatology drugs market. Different dermatological association in Europe region which is increasing the awareness about the skin disease is boosting the growth of market. For instance, European Society of Veterinary Dermatology, is a non-profit organization that supports the development of veterinary dermatology throughout Europe and provides funding for both research and educational programs such as workshops. Presence of leading animal care player such as International GmbH.(France), Vetoquinol S.A.(France), and Virbac(France). is positively impact on market.
Key Players
Some of the key players in global veterinary dermatology drugs market include Bayer HealthCare Animal Health Inc. (U.S.), Boehringer Ingelheim Vetmedica, Inc.(U.S.), Ceva(France), Zoetis Inc.(U.S.), Elanco(U.S.), IDEXX Laboratories(U.S.), Boehringer Ingelheim International GmbH.(France), Vetoquinol S.A.(France), and Virbac(France).
TABLE OF CONTENT
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Veterinary Dermatology Drugs Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
4. By Drug
4.1 Introduction
4.1.1 Market Size & Forecast (Value)
4.2 Non-steroidal anti-inflammatory drugs (NSAIDS)
4.3 Antibiotics
4.4 Veterinary antifungal drug
5. By Animal Type
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Large animals
5.3 Small animals
6. By End Users
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Veterinary Hospitals
5.3 Veterinary Clinics
7. By Regional Overview
7.1 Introduction
7.1.1 Market Size & Forecast (Value)
7.2 America
7.2.1 North America
7.2.1.1 U.S.
7.2.1.1.1 By Drug
7.2.1.1.2 By Animal Type
7.2.1.2 Canada
7.2.1.2.1 By Drug
7.2.1.2.2 By Animal Type
7.2.1.3 Mexico
7.2.1.3.1 By Drug
7.2.1.3.2 By Animal Type
7.2.2 South America
7.2.2.1 By Drug
7.2.2.2 By Animal Type
7.3 Europe
7.3.1 Market Size & Forecast (Value)
7.3.2 Western Europe
7.3.2.1 Germany
7.3.2.1.1 By Drug
8.3.2.1.2 By Animal Type
7.3.2.2 France
7.3.2.2.1 By Drug
7.3.2.2.2 By Animal Type
7.3.2.3 U.K
7.3.2.3.1 By Drug
7.3.2.3.2 By Animal Type
7.3.2.4 Italy
7.3.2.4.1 By Drug
7.3.2.4.2 By Animal Type
7.3.2.5 Spain
7.3.2.5.1 By Drug
7.3.2.5.2 By Animal Type
7.3.2.6 Rest of Western Europe
7.3.2.6.1 By Drug
7.3.2.6.2 By Animal Type
7.3.3 Eastern Europe
7.4 Asia Pacific
7.4.1 Market Size & Forecast (Value)
7.4.2 China
7.4.2.1 By Drug
7.4.2.2 By Animal Type
7.4.3 India
7.4.3.1 By Drug
7.4.3.2 By Animal Type
7.4.4 Japan
7.4.4.1 By Drug
7.4.4.2 By Animal Type
7.4.5 South Korea
7.4.5.1 By Drug
7.4.5.2 By Animal Type
7.4.6 Australia
7.4.6.1 By Drug
7.4.6.2 By Animal Type
7.4.7 Rest of Asia-Pacific
7.4.7.1 By Drug
7.4.7.2 By Animal Type
7.5 Middle East & Africa
7.5.1 Market Size & Forecast (Value)
7.5.2 The Middle East
7.5.2.1 South Africa
7.5.2.1.1 By Drug
7.5.2.1.2 By Animal Type
7.5.2.2 UAE
7.5.2.2.1 By Drug
7.5.2.2.2 By Animal Type
7.5.2.3 Qatar
7.5.2.3.1 By Drug
7.5.2.3.2 By Animal Type
7.5.2.4 Rest of Middle East
7.5.2.4.1 By Drug
7.5.2.4 2 By Animal Type
7.5.3 Africa
7.5.3.1 By Drug
7.5.3.2 By Animal Type
8. Company Profile
8.1 Bayer HealthCare Animal Health Inc.
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Recent Developments
8.1.4 Product Portfolio
8.2 Boehringer Ingelheim Vetmedica, Inc.
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Recent Developments
8.2.4 Product Portfolio
8.3 Zoetis Inc.
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Recent Developments
8.3.4 Product Portfolio
8.4 Elanco
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Recent Developments
8.4.4 Product Portfolio
8.5 IDEXX Laboratories
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Recent Developments
8.5.4 Product Portfolio
8.6 Boehringer Ingelheim International GmbH.
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Recent Developments
8.6.4 Product Portfolio
8.7 Vetoquinol S.A.
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Recent Developments
8.7.4 Product Portfolio
8.8 Virbac
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Recent Developments
8.8.4 Product Portfolio
TABLE 1 Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 2 Non-steroidal anti-inflammatory drugs (NSAIDS) Market Share, By Region, 2016-2026 ($ Million)
TABLE 3 Antibiotics Market Share, By Region, 2016-2026, ($ Million)
TABLE 4 Veterinary Dermatology Drugs Market Share, By Animal Type 2016-2026 ($Million)
TABLE 5 Large Animals Market Share, By Region, 2016-2026 ($ Million)
TABLE 6 Small Animals Market Share, By Region, 2016-2026 ($ Million)
TABLE 7 Veterinary Dermatology Drugs Market Share Value, 2016-2026 ($Million)
TABLE 8 Veterinary Dermatology Drugs Market Share By Region, 2016-2026 ($ Million)
TABLE 9 America Veterinary Dermatology Drugs Market Share Value, By Country, 2016-2026 ($Million)
TABLE 10 America Veterinary Dermatology Drugs Market Share value, By Drug, 2016-2026 ($Million)
TABLE 11 America Veterinary Dermatology Drugs Market Share value, By Animal Type, 2016-2026 ($Million)
TABLE 12 U.S. Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 13 U.S. Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 14 Canada Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 15 Canada Veterinary Dermatology Drugs Market Share, By Animal Type 2016-2026 ($Million)
TABLE 16 Mexico Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 17 Mexico Veterinary Dermatology Drugs Market Share, By Animal Type 2016-2026 ($Million)
TABLE 18 South America Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 19 South America Veterinary Dermatology Drugs Market Share, By Animal Type 2016-2026 ($Million)
TABLE 20 Europe Veterinary Dermatology Drugs Market Share Value, By Region, 2016-2026 ($Million)
TABLE 21 Europe Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 22 Europe Veterinary Dermatology Drugs Market Share, By Animal Type 2016-2026 ($Million)
TABLE 23 Western Europe Veterinary Dermatology Drugs Market Share Value, By Country, 2016-2026 ($Million)
TABLE 24 Western Europe Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 25 Western Europe Veterinary Dermatology Drugs Market Share, By Animal Type 2016-2026 ($Million)
TABLE 26 Germany Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 27 Germany Veterinary Dermatology Drugs Market Share, By Animal Type 2016-2026 ($Million)
TABLE 28 France Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 29 France Veterinary Dermatology Drugs Market Share, By Animal Type 2016-2026 ($Million)
TABLE 30 UK Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 31 UK Veterinary Dermatology Drugs Market Share, By Animal Type 2016-2026 ($Million)
TABLE 32 Italy Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 33 Italy Veterinary Dermatology Drugs Market Share, By Animal Type 2016-2026 ($Million)
TABLE 34 Spain Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 35 Spain Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 36 Rest of Western Europe Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 37 Rest of Western Europe Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 38 Eastern Europe Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 39 Eastern Europe Veterinary Dermatology Drugs Market Share, By Animal Type 2016-2026 ($Million)
TABLE 40 Asia-Pacific Veterinary Dermatology Drugs Market Share, By Country, 2016-2026 ($Million)
TABLE 41 Asia-Pacific Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 42 Asia-Pacific Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 43 Japan Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 44 Japan Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 45 China Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 46 China Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 47 Australia Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 48 Australia Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 49 India Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 50 India Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 51 South Korea Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 52 South Korea Veterinary Dermatology Drugs Market Share, By Animal Type 2016-2026 ($Million)
TABLE 53 Rest of Asia-pacific Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 54 Rest of Asia-pacific Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 55 The Middle East and Africa Veterinary Dermatology Drugs Market Share, By Region, 2016-2026 ($Million)
TABLE 56 The Middle East and Africa Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 57 The Middle East and Africa Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 58 The Middle East Veterinary Dermatology Drugs Market Share, By Country, 2016-2026 ($Million)
TABLE 59 The Middle East Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 60 The Middle East Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 61 Saudi Arabia Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 62 Saudi Arabia Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 63 UAE Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 64 UAE Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 65 Qatar Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 66 Qatar Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
TABLE 67 Africa Veterinary Dermatology Drugs Market Share, By Country, 2016-2026 ($Million)
TABLE 68 Africa Veterinary Dermatology Drugs Market Share, By Drug, 2016-2026 ($Million)
TABLE 69 Africa Veterinary Dermatology Drugs Market Share, By Animal Type, 2016-2026 ($Million)
List of Figures
FIGURE 1 Veterinary Dermatology Drugs Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 5 Threat of Substitutes
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Veterinary Dermatology Drugs Market, 2016-2026
FIGURE 9 U.S. Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 10 Canada Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 11 Mexico Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 12 South America Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 13 Western Europe Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 14 Germany Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 15 France Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 16 UK Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 17 Italy Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 18 Spain Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 19 Rest of Western Europe Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 20 Eastern Europe Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 21 Japan Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 22 China Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 23 Australia Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 24 India Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 25 South Korea Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 26 Rest of Asia-pacific Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 27 The Middle East Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 28 Saudi Arabia Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 29 UAE Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 30 Qatar Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 31 Rest of The Middle East Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 32 Africa Veterinary Dermatology Drugs Market Share, 2016-2026 ($Million)
FIGURE 33 Bayer HealthCare Animal Health Inc.: Revenue Analysis, ($ million)
FIGURE 34 Bayer HealthCare Animal Health Inc.: Segment Revenue 2017 (%)